drugset / Trial / NCT01458587

Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)

NCT01458587

Phase 2 Completed 70 enrolled DUSA Pharmaceuticals, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if Levulan PDT is safe and effective in the treatment of actinic keratoses on the upper arms and hands.

Timeline

Start
2011-11
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminolevulinic Acid Diagnostic / imaging agent 20 % Topical

Indications